10x Genomics ships Atera, a breakthrough spatial biology platform with global research demand.

10x Genomics has begun shipping Atera, a new spatial biology platform that combines whole transcriptome analysis, single-cell sensitivity, and large-scale capabilities. This platform removes previous limitations in spatial studies, enabling researchers worldwide to explore complex biological questions across diseases like cancer, neurodegeneration, and autoimmune disorders. Early adopters include leading institutes and biopharma companies, with plans to expand research applications and integrate AI-driven biological models. Future enhancements will add automation, multiomics, and mutation detection, promising to transform biological research and drug development.

10x Genomics (TXG) trades at USD 89.05 on Pluang as of Sep 29, 2026 20:11 WIB, showing a 1-day gain of 0.62%. The stock has a market cap of $11.53 billion and an enterprise value of $11.06 billion. Pluang users are almost evenly split in order activity, with 51% buying and 49% selling, reflecting balanced investor interest.